i3 BioMedical Inc. today announced that a team of scientists at the University 
of Toronto tested and established that the virus SARS-CoV-2, which causes 
Covid-19, cannot be recovered after being applied to the TrioMed Active mask. 
The mask's external surface deactivates >99% of the Coronavirus suspension 
within minutes.

Photo - 
https://mma.prnewswire.com/media/1213779/I3_BioMedical_Inc__University_of_Toronto_Tests_Confirm_First_Mas.jpg


The TrioMed Active Mask type IIR surgical mask incorporates TrioMed's 
technology and provides an advanced level of active protection for healthcare 
workers and the general population. The patented antimicrobial technology is at 
the core of the company's entire line of medical products such as wound 
dressings, medical tapes, gloves, headwear, gowns and other personal protective 
equipment sold globally.

A study published in the American Journal of Infection Control established that 
people touch their face 23 times per hour on average(1). Furthermore, the 
coronavirus that causes Covid-19 remains present and infectious on the outer 
layer of masks for up to 7 days, according to a study published in The Lancet 
Microbe(2). In addition to the warnings issued by governmental authorities 
pertaining to self-contamination by touching one's mask, these two scientific 
publications further demonstrate the major deficiency in the level of 
protection for all wearers of current masks.

"The TrioMed Active Mask is the first and only respiratory protection that is 
scientifically proven to deactivate the virus causing Covid-19, therefore 
drastically reducing the risk of contamination for the wearer", says Pierre 
Jean Messier, founder and CEO of i3 Biomedical Inc. "Our company spent years 
and millions of dollars to develop this interactive antimicrobial technology. 
The resulting products are used by the medical community around the world and 
have been tested by independent laboratories to kill numerous microbes, such as 
MRSA, VRE, E-Coli, Staphylococcus Aureus, Influenza Virus and now SARS-CoV-2. 
This third-party scientific testing confirms TrioMed's leading position in 
medical antimicrobial technology available in the global fight against 
Covid-19." 

Features and benefits of the TrioMed Active mask include:

  -- Active antimicrobial protection of the mask outer layer deactivates >99%
     of the Coronavirus SARS 2 and Influenza virus H1N1 
  -- Viral filtration efficiency (VFE) > 99.9% 
  -- Bacterial filtration efficiency (BFE) > 99.9% 
  -- Meets ASTM F2100 Level 3 
  -- Meets European Medical Device standard EN 14683 Type IIR 
  -- Five-year shelf life

About i3 BioMedical Inc: i3 BioMedical is a Canadian company, focused on the 
development and manufacturing of novel antimicrobial products that help prevent 
the spread of infection and disease. 

  (1) Kwok YL, Gralton J, McLaws ML. Face touching: a frequent habit that has
      implications for hand hygiene. Am J Infect Control. 2015;43(2):112-114.
      doi:10.1016/j.ajic.2014.10.015
  (2) Chin A W H, Chu J T S, Perera M R A, et al. Stability of SARS-CoV-2 in
      different environmental conditions. Lancet Microbe 2020; published online
      April 2. https://doi.org/10.1016/S2666-5247(20)30003-3.


For more information on the TrioMed Active face masks, visit: www.triomed.com 
or send an email to triomed@triomed.com; media.relations@utoronto.ca

SOURCE: I3 BioMedical Inc.